Michael Celano
2019 - Recro Pharma
In 2019, Michael Celano earned a total compensation of $1.7M as Chief Operating Officer at Recro Pharma, a 43% increase compared to previous year.
Compensation breakdown
| Option Awards | $635,331 |
|---|---|
| Salary | $167,721 |
| Stock Awards | $416,753 |
| Other | $478,804 |
| Total | $1,698,609 |
Celano received $635.3K in option awards, accounting for 37% of the total pay in 2019.
Celano also received $167.7K in salary, $416.8K in stock awards and $478.8K in other compensation.
Rankings
In 2019, Michael Celano's compensation ranked 6,713th out of 13,971 executives tracked by ExecPay. In other words, Celano earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,713 out of 13,971 | 52nd |
Division Manufacturing | 2,556 out of 5,695 | 55th |
Major group Chemicals And Allied Products | 935 out of 2,194 | 57th |
Industry group Drugs | 790 out of 1,880 | 58th |
Industry Pharmaceutical Preparations | 577 out of 1,392 | 59th |
Source: SEC filing on March 27, 2020.
Celano's colleagues
We found three more compensation records of executives who worked with Michael Celano at Recro Pharma in 2019.